UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its pipeline ahead of a key patent expiry, as US hedge fund Citadel took the largest short position ...
Teva Pharmaceutical Industries Ltd. ADR-0.93% $19.32B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback